Contact: Michael C. Purdy
Washington University School of Medicine
Caption: A mutated protein that causes an inherited form of Lou Gehrig's disease leads to clumps in the human cells in the bottom image. A therapy that blocks production of this protein has passed phase one safety trials.
Credit: Matthew J. Crisp
Usage Restrictions: Please include credit.
Related news release: ALS trial shows novel therapy is safe